Article(id=1329875939158241874, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329875908023922880, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.12.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1703692800000, receivedDateStr=2023-12-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794996731794, onlineDateStr=2026-11-18, pubDate=1733760000000, pubDateStr=2024-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794996731794, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794996731794, creator=13701087609, updateTime=1794996731794, updator=13701087609, issue=Issue{id=1329875908023922880, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='12', pageStart='1603', pageEnd='1728', issueExtLink='null', onlineDate='null', pubDate='1733760000000', pubDateStr='2024-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794996724372, creator='13701087609', updateTime=1794996724372, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext=null, issueFiles=null, downloadFileDto=null}, startPage=1619, endPage=1627, ext={EN=ArticleExt(id=1329875939351179859, articleId=1329875939158241874, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress on Antitumor Mechanisms and Nano-based Delivery Systems of Concomitant Use of Curcumin and Doxorubicin, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Doxorubicin is one of the potent drugs in the clinic for the treatment of blood cancers and solid tumors. However, side effects and drug resistance of doxorubicin pose major obstacles to its application in antitumor therapy. Curcumin exhibits multiple pharmacological effects such as antitumor activity, antioxidation, and anti-inflammation. When combined with doxorubicin, curcumin can enhance efficacy, reduce toxicity, and reverse multidrug resistance. Nevertheless, due to the poor solubility, instability, and low bioavailability of curcumin, the application of this combination therapy is limited. Currently, the nano drug co-delivery system offers numerous advantages in antitumor therapy. A nano-based co-loading delivery system of curcumin and doxorubicin can improve drug solubility, enhance stability, achieve targeted drug aggregation, and realize sustained- and controlled- release at the tumor site. This review summarizes the antitumor mechanisms of the concomitant use of curcumin and doxorubicin and their novel nano-based drug delivery systems in recent years, providing ideas for further research on this combination therapy and the development and application of their nano-formulations.

, authors=Shengguang WU, Lianghui HUANG, Minquan ZHANG, Mingcheng GONG, Liangliang ZHOU*, Zhenhua CHEN*, authorsList=Shengguang WU, Lianghui HUANG, Minquan ZHANG, Mingcheng GONG, Liangliang ZHOU, Zhenhua CHEN, authorCompany=null, correspAuthors=Liangliang ZHOU, Zhenhua CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329875939628003924, articleId=1329875939158241874, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=姜黄素与多柔比星联用的抗肿瘤机制及其纳米递送系统的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

多柔比星是临床用于血液和实体瘤治疗的强效药物之一,但其诱导的不良反应和耐药性是抗肿瘤治疗应用中的主要障碍。姜黄素具有抗肿瘤、抗氧化和抗炎等多种药理作用,与多柔比星联用,可达到对多柔比星的增效、减毒、逆转多药耐药性作用。然而,因姜黄素具有溶解性差、稳定性差、生物利用度低等缺陷,使二者联合用药的应用受到限制。目前,纳米共递送系统在抗肿瘤治疗中具有多方面优势,将姜黄素与多柔比星封装到同一纳米递药系统可提高药物溶解度、增强稳定性、实现药物在肿瘤部位靶向富集和缓控释等。文章归纳了近年来姜黄素与多柔比星联用的抗肿瘤机制及其新型纳米递送系统,为二者联用的深入研究及其制剂的开发和应用提供一定思路。

, authors=吴胜广, 黄良辉, 张民权, 龚铭城, 周良良*, 陈振华*, authorsList=吴胜广, 黄良辉, 张民权, 龚铭城, 周良良, 陈振华, authorCompany=null, correspAuthors=周良良, 陈振华, authorNote=

吴胜广(1999—),男,硕士研究生,专业方向:药物新剂型及质量评价。

, correspAuthorsNote=
陈振华(1982—),男,教授,从事药物新剂型及质量评价的研究。E-mail:
周良良(1986—),男,讲师,从事中药制剂的研究与开发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=5m25VsJBFzaF0Z/3JBcEoQ==, magXml=vEAlwbvwXG+0bskMYT2+ZQ==, pdfUrl=null, pdf=go/9uuxoYAIyWKIk7JPNVA==, pdfFileSize=1764219, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=6GB/b4jBGy8rnZtMhHruqA==, mapNumber=null, fund=null)}, authors=[Author(id=1329875939879662169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875939946771035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875939879662169, language=EN, stringName=Shengguang WU, firstName=Shengguang, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940005491292, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875939879662169, language=CN, stringName=吴胜广, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio={"content":"

吴胜广(1999—),男,硕士研究生,专业方向:药物新剂型及质量评价。

"}, bioImg=null, bioContent=

吴胜广(1999—),男,硕士研究生,专业方向:药物新剂型及质量评价。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940055822942, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875940127126112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940055822942, language=EN, stringName=Lianghui HUANG, firstName=Lianghui, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940202623585, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940055822942, language=CN, stringName=黄良辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940269732451, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875940345229925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940269732451, language=EN, stringName=Minquan ZHANG, firstName=Minquan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940408144486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940269732451, language=CN, stringName=张民权, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940513002088, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875940584305258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940513002088, language=EN, stringName=Mingcheng GONG, firstName=Mingcheng, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940659802731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940513002088, language=CN, stringName=龚铭城, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940722717293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=3066340062@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875940789826159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940722717293, language=EN, stringName=Liangliang ZHOU, firstName=Liangliang, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940898878064, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940722717293, language=CN, stringName=周良良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940965986930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhenhuachen@jxstnu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875941045678708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940965986930, language=EN, stringName=Zhenhua CHEN, firstName=Zhenhua, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875941154730613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940965986930, language=CN, stringName=陈振华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])])], keywords=[Keyword(id=1329875941238616694, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=EN, orderNo=1, keyword=curcumin), Keyword(id=1329875941297336951, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=EN, orderNo=2, keyword=doxorubicin), Keyword(id=1329875941381223032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=EN, orderNo=3, keyword=antineoplastics), Keyword(id=1329875941444137593, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=EN, orderNo=4, keyword=multidrug resistance), Keyword(id=1329875941502857850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=EN, orderNo=5, keyword=nano-based drug delivery system), Keyword(id=1329875941561578107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=EN, orderNo=6, keyword=research progress), Keyword(id=1329875941624492668, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=CN, orderNo=1, keyword=姜黄素), Keyword(id=1329875941695795837, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=CN, orderNo=2, keyword=多柔比星), Keyword(id=1329875941750321790, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=CN, orderNo=3, keyword=抗肿瘤药), Keyword(id=1329875941813236351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=CN, orderNo=4, keyword=多药耐药性), Keyword(id=1329875941876150912, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=CN, orderNo=5, keyword=纳米药物递送系统), Keyword(id=1329875941947454081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, language=CN, orderNo=6, keyword=研究进展)], refs=[Reference(id=1329875942052311682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=KASSAB J, SABA L, GEBRAEL G, et al.Update on immunotherapy in the management of gallbladder cancer [J].Immunotherapy, 2023, 15(1): 35-42., articleTitle=null, refAbstract=null), Reference(id=1329875942119420547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=SOHAIL M, SUN Z, LI Y L, et al.Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy [J].Expert Rev Anticancer Ther, 2021, 21(12): 1385-1398., articleTitle=null, refAbstract=null), Reference(id=1329875942199112324, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU L S, LIN M.The synthesis of nano-doxorubicin and its anticancer effect [J].Anticancer Agents Med Chem, 2021, 21(18): 2466-2477., articleTitle=null, refAbstract=null), Reference(id=1329875942262026885, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y N, RAUF KHAN A, FU M F, et al.Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks [J].J Drug Target, 2019, 27(9): 917-931., articleTitle=null, refAbstract=null), Reference(id=1329875942396244614, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLENBACHER E, KHAN S Z, MUJICA S C A, et al.Curcumin: new insights into an ancient ingredient against cancer [J].Int J Mol Sci, 2019, 20(8): 1808., articleTitle=null, refAbstract=null), Reference(id=1329875942459159175, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=YAGHOUBI F, MOTLAGH N S H, NAGHIB S M, et al.A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment [J].Sci Rep, 2022, 12(1): 1959., articleTitle=null, refAbstract=null), Reference(id=1329875942543045256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=TIWARI A, JAIN S K.Curcumin based drug delivery systems for cancer therapy [J].Curr Pharm Des, 2020, 26(42): 5430-5440., articleTitle=null, refAbstract=null), Reference(id=1329875942601765513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=AMEKYEH H, ALKHADER E, SABRA R, et al.Prospects of curcumin nanoformulations in cancer management [J].Molecules, 2022, 27(2): 361., articleTitle=null, refAbstract=null), Reference(id=1329875942664680074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=姜智慧,陆晓媛,周健.姜黄素对人宫颈癌细胞株HeLa细胞增殖的作用的研究以及p53表达的影响[J].中国医学创新,2013,10(12):9-12., articleTitle=null, refAbstract=null), Reference(id=1329875942723400331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ALLEGRA A, INNAO V, RUSSO S, et al.Anticancer activity of curcumin and its analogues: preclinical and clinical studies [J].Cancer Invest, 2017, 35(1): 1-22., articleTitle=null, refAbstract=null), Reference(id=1329875942777926284, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=涂启敏,黄宏灵.PI3K/AKT/mTOR在姜黄素抑制食管癌细胞增殖中的作用[J].解剖学研究,2018,40(3):174-177., articleTitle=null, refAbstract=null), Reference(id=1329875942840840845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FU H B, WANG C M, YANG D J, et al.Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling [J].J Cell Physiol, 2018, 233(6): 4634-4642., articleTitle=null, refAbstract=null), Reference(id=1329875942899561102, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=王晶宇,王志平,赵俊丽,等.姜黄素作用PTEN/PI3K/AKT通路诱导膀胱癌EJ细胞凋亡[J].中药药理与临床,2011,27(1):26-28., articleTitle=null, refAbstract=null), Reference(id=1329875942979252879, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SHA J, LI J S, WANG W, et al.Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling [J].Biomed Pharmacother, 2016, 84: 177-184., articleTitle=null, refAbstract=null), Reference(id=1329875943037973136, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=MOU S F, ZHOU Z X, HE Y K, et al.Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a [J].Oncol Lett, 2017, 14(4): 4937-4942., articleTitle=null, refAbstract=null), Reference(id=1329875943092499089, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=AL-KAHTANI M, ABDEL-DAIM M M, SAYED A A, et al.Curcumin phytosome modulates aluminum-induced hepatotoxicity via regulation of antioxidant, Bcl-2, and caspase-3 in rats [J].Environ Sci Pollut Res Int, 2020, 27(17): 21977-21985., articleTitle=null, refAbstract=null), Reference(id=1329875943163802258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=HARAKEH S, SABER S H, AL-RADDADI R, et al.Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells [J].Artif Cells Nanomed Biotechnol, 2023, 51(1): 361-370., articleTitle=null, refAbstract=null), Reference(id=1329875943239299731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=AGUDELO D, BOURASSA P, BÉRUBÉ G, et al.Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity [J].J Photochem Photobiol B, 2016, 158: 274-279., articleTitle=null, refAbstract=null), Reference(id=1329875943293825684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG T S, WANG J B, SONG X, et al.Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways [J].J Cancer Res Clin Oncol, 2010, 136(10): 1597., articleTitle=null, refAbstract=null), Reference(id=1329875943352545941, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=MANNA S K, GANGADHARAN C, EDUPALLI D, et al.Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells [J].J Biol Chem, 2013, 288(9): 8562., articleTitle=null, refAbstract=null), Reference(id=1329875943415460502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=SUMIRTANURDIN R, SUNGKAR S, HISPRASTIN Y, et al.Molecular docking simulation studies of curcumin and its derivatives as cyclin-dependent kinase 2 inhibitors [J].Turk J Pharm Sci, 2020, 17(4): 417-423., articleTitle=null, refAbstract=null), Reference(id=1329875943465792151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO X L, LEONE G W, WANG H Z.Cyclin D-CDK4/6 functions in cancer [J].Adv Cancer Res, 2020, 148: 147-169., articleTitle=null, refAbstract=null), Reference(id=1329875943528706712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SHIMIZU A, NISHIDA J, UEOKA Y, et al.CyclinG contributes to G2/M arrest of cells in response to DNA damage [J].Biochem Biophys Res Commun, 1998, 242(3): 529-533., articleTitle=null, refAbstract=null), Reference(id=1329875943620981401, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG T S, XIAO Y, LIU S, et al.Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer [J].Phytomedicine, 2023, 114: 154780., articleTitle=null, refAbstract=null), Reference(id=1329875943692284570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUEAHONGTHONG F, TIMA S, CHIAMPANICHAYAKUL S, et al.Co-treatments of edible curcumin from turmeric rhizomes and chemotherapeutic drugs on cytotoxicity and FLT3 protein expression in leukemic stem cells [J].Molecules, 2021, 26(19): 5785., articleTitle=null, refAbstract=null), Reference(id=1329875943751004827, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU D J, LI Y, ZHANG Z J, et al.Recent advances of nanotechnology-based tumor vessel-targeting strategies [J].J Nanobiotechnology, 2021, 19(1): 435., articleTitle=null, refAbstract=null), Reference(id=1329875943805530780, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=陈彩萍,徐琦,赵海菲.姜黄素对肝癌细胞miR-29及VEGF表达的干预作用[J].浙江中西医结合杂志,2020,30(10):785-790., articleTitle=null, refAbstract=null), Reference(id=1329875943864251037, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=杨传玉,曾荣耀,刘荣亮,等.姜黄素对化学诱导大鼠肝癌缺氧模型血管生成的影响[J].中国肿瘤生物治疗杂志,2018,25(2):137-141., articleTitle=null, refAbstract=null), Reference(id=1329875943935554206, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG C Y, ZHANG R S, HE J, et al.Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity [J].Nat Commun, 2023, 14(1): 3877., articleTitle=null, refAbstract=null), Reference(id=1329875944023634591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=SYUKRI A, BUDU, HATTA M, et al.Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage [J].Ann Med Surg (Lond), 2022, 76: 103501., articleTitle=null, refAbstract=null), Reference(id=1329875944082354848, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=FINCK A, GILL S I, JUNE C H.Cancer immunotherapy comes of age and looks for maturity [J].Nat Commun, 2020, 11(1): 3325., articleTitle=null, refAbstract=null), Reference(id=1329875944141075105, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=KROEMER G, GALASSI C, ZITVOGEL L, et al.Immunogenic cell stress and death [J].Nat Immunol, 2022, 23(4): 487-500., articleTitle=null, refAbstract=null), Reference(id=1329875944203989666, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=FAROOQI A A, LI K T, FAYYAZ S, et al.Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress [J].Tumour Biol, 2015, 36(8): 5743-5752., articleTitle=null, refAbstract=null), Reference(id=1329875944275292835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=MAU B L, POWIS G.Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin.Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity [J].Biochem Pharmacol, 1992, 43(7): 1621-1627., articleTitle=null, refAbstract=null), Reference(id=1329875944346596004, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=QI J, JIN F Y, YOU Y C, et al.Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles [J].Nat Commun, 2021, 12(1): 4755., articleTitle=null, refAbstract=null), Reference(id=1329875944417899173, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG J, WANG Y, LIU Q, et al.Rational design of multifunctional dendritic mesoporous silica nanoparticles to load curcumin and enhance efficacy for breast cancer therapy[J].ACS Appl Mater Interfaces, 2016, 8(40): 26511-26523., articleTitle=null, refAbstract=null), Reference(id=1329875944493396646, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=DAI Z, TANG J, GU Z Y, et al.Eliciting immunogenic cell death via a unitized nanoinducer [J].Nano Lett, 2020, 20(9): 6246-6254., articleTitle=null, refAbstract=null), Reference(id=1329875944560505511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Y Q, ZHU J, YANG Y F, et al.Long-acting nanohybrid hydrogel induces persistent immunogenic chemotherapy for suppressing postoperative tumor recurrence and metastasis [J].Mol Pharm, 2023, 20(12): 6345-6357., articleTitle=null, refAbstract=null), Reference(id=1329875944623420073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO A C, MA P Q, YANG T, et al.Multifunctionalized micelles facilitate intracellular doxorubicin delivery for reversing multidrug resistance of breast cancer [J].Mol Pharm, 2019, 16(6): 2502-2510., articleTitle=null, refAbstract=null), Reference(id=1329875944711500458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG N, GAO M, WANG Z H, et al.Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level [J].J Pharm Biomed Anal, 2021, 201: 114129., articleTitle=null, refAbstract=null), Reference(id=1329875944791192235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=WU M F, HUANG Y H, CHIU L Y, et al.Curcumin induces apoptosis of chemoresistant lung cancer cells via ROS-regulated p38 MAPK phosphorylation [J].Int J Mol Sci, 2022, 23(15): 8248., articleTitle=null, refAbstract=null), Reference(id=1329875944862495404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=AN L L, WURI J, ZHENG Z T, et al.Microbiota modulate doxorubicin induced cardiotoxicity [J].Eur J Pharm Sci, 2021, 166: 105977., articleTitle=null, refAbstract=null), Reference(id=1329875944921215661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=朱俊峰,伊晓娇,钟里科,等.中药抗阿霉素心脏毒性的中医理论及其药理作用研究进展[J].中华中医药杂志,2022,37(8):4592-4598., articleTitle=null, refAbstract=null), Reference(id=1329875944975741614, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=NAMDARI M, EATEMADI A.Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite(nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines [J].Artif Cells Nanomed Biotechnol, 2017, 45(4): 731-739., articleTitle=null, refAbstract=null), Reference(id=1329875945047044783, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUANG S E, YEH P Y, LU Y S, et al.Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB(NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells [J].Biochem Pharmacol, 2002, 63(9): 1709-1716., articleTitle=null, refAbstract=null), Reference(id=1329875945118347952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=SOMPAR N, KUKONGVIRIYAPAN V, KUKONGVIRIYAPAN U, et al.Protective effects of tetrahydrocurcumin and curcumin against doxorubicin and cadmium-induced cytotoxicity in chang liver cells [J].Trop J Pharm Res, 2015, 14(5): 769-776., articleTitle=null, refAbstract=null), Reference(id=1329875945172873905, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=YU W, QIN X, ZHANG Y C, et al.Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner [J].Cardiovasc Diagn Ther, 2020, 10(4): 752-769., articleTitle=null, refAbstract=null), Reference(id=1329875945239982770, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=SHARIFIAGHDAM Z, DALOUCHI F, SHARIFIAGHDAM M, et al.Curcumin-coated gold nanoparticles attenuate doxorubicin-induced cardiotoxicity via regulating apoptosis in a mouse model [J].Clin Exp Pharmacol Physiol, 2022, 49(1): 70-83., articleTitle=null, refAbstract=null), Reference(id=1329875945302897331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=KATAMURA M, IWAI-KANAI E, NAKAOKA M, et al.Curcumin attenuates doxorubicin-induced cardiotoxicity by inducing autophagy via the regulation of JNK phosphorylation[J].J Clin Exp Cardiol, 2014, (5): 337., articleTitle=null, refAbstract=null), Reference(id=1329875945437115060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=JUNKUN L, ERFU C, TONY H, et al.Curcumin downregulates phosphate carrier and protects against doxorubicin induced cardiomyocyte apoptosis [J].Biomed Res Int, 2016, 2016: 1980763., articleTitle=null, refAbstract=null), Reference(id=1329875945500029621, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=LARGE D E, ABDELMESSIH R G, FINK E A, et al.Liposome composition in drug delivery design, synthesis, characterization, and clinical application [J].Adv Drug Deliv Rev, 2021, 176: 113851., articleTitle=null, refAbstract=null), Reference(id=1329875945567138486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=FAN Y C, MARIOLI M, ZHANG K.Analytical characterization of liposomes and other lipid nanoparticles for drug delivery [J].J Pharm Biomed Anal, 2021, 192(59): 113642., articleTitle=null, refAbstract=null), Reference(id=1329875945625858743, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=MURUGESAN K, SRINIVASAN P, MAHADEVA R, et al.Tuftsin-bearing liposomes co-encapsulated with doxorubicin and curcumin efficiently inhibit EAC tumor growth in mice [J].Int J Nanomedicine, 2020, 15: 10547-10559., articleTitle=null, refAbstract=null), Reference(id=1329875945680384696, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=陈仕红.姜黄素和阿霉素双载药靶向脂质体的制备及抗肿瘤活性研究[D].武汉:湖北中医药大学硕士学位论文,2019., articleTitle=null, refAbstract=null), Reference(id=1329875945760076473, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=HWANG D, RAMSEY J D, KABANOV A V.Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval [J].Adv Drug Deliv Rev, 2020, 156: 80-118., articleTitle=null, refAbstract=null), Reference(id=1329875945822991034, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=GU Y, LI J, LI Y, et al.Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer [J].Int J Nanomedicine, 2016, 11: 5757-5770., articleTitle=null, refAbstract=null), Reference(id=1329875945923654331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=SABZI A, RAHMANI A, EDALATI M, et al.Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized poly(ε-caprolactone) based micelle in MDA-MB-231 cell [J].Colloids Surf B Biointerfaces, 2020, 194: 111225., articleTitle=null, refAbstract=null), Reference(id=1329875946007540412, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=ÖZKAN SA, DEDEOĞLU A, KARADAŞ BAKIRHAN N, et al.Nanocarriers used most in drug delivery and drug release: nanohydrogel, chitosan, graphene, and solid lipid [J].Turk J Pharm Sci, 2019, 16(4): 481-492., articleTitle=null, refAbstract=null), Reference(id=1329875946099815101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=ABEDI F, DAVARAN S, HEKMATI M, et al.An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells [J].J Nanobiotechnology, 2021, 19(1): 18., articleTitle=null, refAbstract=null), Reference(id=1329875946183701182, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=RONG L D, LIU Y, FAN Y, et al.Injectable nano-composite hydrogels based on hyaluronic acid-chitosan derivatives for simultaneous photothermal-chemo therapy of cancer with anti-inflammatory capacity [J].Carbohydr Polym, 2023, 310: 120721., articleTitle=null, refAbstract=null), Reference(id=1329875946242421439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Z J, TONG Q, LI T, et al.Nano drugs delivery system: a novel promise for the treatment of atrial fibrillation[J].Front Cardiovasc Med, 2022, 9: 906350., articleTitle=null, refAbstract=null), Reference(id=1329875946305336000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO F Y, YU N, JIAO Y L, et al.Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer [J].Drug Deliv, 2021, 28(1): 1709-1721., articleTitle=null, refAbstract=null), Reference(id=1329875946368250561, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J, LI L, ZHANG B, et al.MnO2-shelled doxorubicin/curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy [J].J Colloid Interface Sci, 2022, 617: 315-325., articleTitle=null, refAbstract=null), Reference(id=1329875946439553730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=YE J H, AUGUSTIN M A.Nano- and micro-particles for delivery of catechins: physical and biological performance [J].Crit Rev Food Sci Nutr, 2019, 59(10): 1563-1579., articleTitle=null, refAbstract=null), Reference(id=1329875946498273987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN J T, YE Q B, YANG Q J, et al.Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin [J].Colloids Surf B Biointerfaces, 2019, 180: 93-101., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.12.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.12.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.12.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.12.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1733760000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
姜黄素与多柔比星联用的抗肿瘤机制及其纳米递送系统的研究进展
吴胜广 , 黄良辉 , 张民权 , 龚铭城 , 周良良 * , 陈振华 *
中国医药工业杂志 | 综述 2024,55(12): 1619-1627
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (12) : 1619 -1627
姜黄素与多柔比星联用的抗肿瘤机制及其纳米递送系统的研究进展
全屏
[Author(id=1329875939879662169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875939946771035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875939879662169, language=EN, stringName=Shengguang WU, firstName=Shengguang, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940005491292, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875939879662169, language=CN, stringName=吴胜广, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio={"content":"

吴胜广(1999—),男,硕士研究生,专业方向:药物新剂型及质量评价。

"}, bioImg=null, bioContent=

吴胜广(1999—),男,硕士研究生,专业方向:药物新剂型及质量评价。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940055822942, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875940127126112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940055822942, language=EN, stringName=Lianghui HUANG, firstName=Lianghui, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940202623585, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940055822942, language=CN, stringName=黄良辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940269732451, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875940345229925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940269732451, language=EN, stringName=Minquan ZHANG, firstName=Minquan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940408144486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940269732451, language=CN, stringName=张民权, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940513002088, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875940584305258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940513002088, language=EN, stringName=Mingcheng GONG, firstName=Mingcheng, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940659802731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940513002088, language=CN, stringName=龚铭城, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940722717293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=3066340062@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875940789826159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940722717293, language=EN, stringName=Liangliang ZHOU, firstName=Liangliang, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875940898878064, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940722717293, language=CN, stringName=周良良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])]), Author(id=1329875940965986930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhenhuachen@jxstnu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875941045678708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940965986930, language=EN, stringName=Zhenhua CHEN, firstName=Zhenhua, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875941154730613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, authorId=1329875940965986930, language=CN, stringName=陈振华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875939791581781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, xref=null, ext=[AuthorCompanyExt(id=1329875939799970390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013), AuthorCompanyExt(id=1329875939808358999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875939158241874, companyId=1329875939791581781, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013)])])]
吴胜广, 黄良辉, 张民权, 龚铭城, 周良良* , 陈振华*
作者信息
  • 江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013
通讯作者:
陈振华(1982—),男,教授,从事药物新剂型及质量评价的研究。E-mail:
周良良(1986—),男,讲师,从事中药制剂的研究与开发。E-mail:
作者简介:

吴胜广(1999—),男,硕士研究生,专业方向:药物新剂型及质量评价。

Research Progress on Antitumor Mechanisms and Nano-based Delivery Systems of Concomitant Use of Curcumin and Doxorubicin
Shengguang WU, Lianghui HUANG, Minquan ZHANG, Mingcheng GONG, Liangliang ZHOU* , Zhenhua CHEN*
Affiliations
  • Jiangxi Provincial Key Lab. of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013
出版时间: 2024-12-10 doi: 10.16522/j.cnki.cjph.2024.12.003
文章导航
收藏切换

多柔比星是临床用于血液和实体瘤治疗的强效药物之一,但其诱导的不良反应和耐药性是抗肿瘤治疗应用中的主要障碍。姜黄素具有抗肿瘤、抗氧化和抗炎等多种药理作用,与多柔比星联用,可达到对多柔比星的增效、减毒、逆转多药耐药性作用。然而,因姜黄素具有溶解性差、稳定性差、生物利用度低等缺陷,使二者联合用药的应用受到限制。目前,纳米共递送系统在抗肿瘤治疗中具有多方面优势,将姜黄素与多柔比星封装到同一纳米递药系统可提高药物溶解度、增强稳定性、实现药物在肿瘤部位靶向富集和缓控释等。文章归纳了近年来姜黄素与多柔比星联用的抗肿瘤机制及其新型纳米递送系统,为二者联用的深入研究及其制剂的开发和应用提供一定思路。

姜黄素  /  多柔比星  /  抗肿瘤药  /  多药耐药性  /  纳米药物递送系统  /  研究进展

Doxorubicin is one of the potent drugs in the clinic for the treatment of blood cancers and solid tumors. However, side effects and drug resistance of doxorubicin pose major obstacles to its application in antitumor therapy. Curcumin exhibits multiple pharmacological effects such as antitumor activity, antioxidation, and anti-inflammation. When combined with doxorubicin, curcumin can enhance efficacy, reduce toxicity, and reverse multidrug resistance. Nevertheless, due to the poor solubility, instability, and low bioavailability of curcumin, the application of this combination therapy is limited. Currently, the nano drug co-delivery system offers numerous advantages in antitumor therapy. A nano-based co-loading delivery system of curcumin and doxorubicin can improve drug solubility, enhance stability, achieve targeted drug aggregation, and realize sustained- and controlled- release at the tumor site. This review summarizes the antitumor mechanisms of the concomitant use of curcumin and doxorubicin and their novel nano-based drug delivery systems in recent years, providing ideas for further research on this combination therapy and the development and application of their nano-formulations.

curcumin  /  doxorubicin  /  antineoplastics  /  multidrug resistance  /  nano-based drug delivery system  /  research progress
吴胜广, 黄良辉, 张民权, 龚铭城, 周良良, 陈振华. 姜黄素与多柔比星联用的抗肿瘤机制及其纳米递送系统的研究进展. 中国医药工业杂志, 2024 , 55 (12) : 1619 -1627 . DOI: 10.16522/j.cnki.cjph.2024.12.003
Shengguang WU, Lianghui HUANG, Minquan ZHANG, Mingcheng GONG, Liangliang ZHOU, Zhenhua CHEN. Research Progress on Antitumor Mechanisms and Nano-based Delivery Systems of Concomitant Use of Curcumin and Doxorubicin[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (12) : 1619 -1627 . DOI: 10.16522/j.cnki.cjph.2024.12.003

参考文献 引证文献
排序方式:
[1]
KASSAB J, SABA L, GEBRAEL G, et al.Update on immunotherapy in the management of gallbladder cancer [J].Immunotherapy, 2023, 15(1): 35-42.
[2]
SOHAIL M, SUN Z, LI Y L, et al.Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy [J].Expert Rev Anticancer Ther, 2021, 21(12): 1385-1398.
[3]
ZHU L S, LIN M.The synthesis of nano-doxorubicin and its anticancer effect [J].Anticancer Agents Med Chem, 2021, 21(18): 2466-2477.
[4]
ZHANG Y N, RAUF KHAN A, FU M F, et al.Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks [J].J Drug Target, 2019, 27(9): 917-931.
[5]
WILLENBACHER E, KHAN S Z, MUJICA S C A, et al.Curcumin: new insights into an ancient ingredient against cancer [J].Int J Mol Sci, 2019, 20(8): 1808.
[6]
YAGHOUBI F, MOTLAGH N S H, NAGHIB S M, et al.A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment [J].Sci Rep, 2022, 12(1): 1959.
[7]
TIWARI A, JAIN S K.Curcumin based drug delivery systems for cancer therapy [J].Curr Pharm Des, 2020, 26(42): 5430-5440.
[8]
AMEKYEH H, ALKHADER E, SABRA R, et al.Prospects of curcumin nanoformulations in cancer management [J].Molecules, 2022, 27(2): 361.
[9]
姜智慧,陆晓媛,周健.姜黄素对人宫颈癌细胞株HeLa细胞增殖的作用的研究以及p53表达的影响[J].中国医学创新,2013,10(12):9-12.
[10]
ALLEGRA A, INNAO V, RUSSO S, et al.Anticancer activity of curcumin and its analogues: preclinical and clinical studies [J].Cancer Invest, 2017, 35(1): 1-22.
[11]
涂启敏,黄宏灵.PI3K/AKT/mTOR在姜黄素抑制食管癌细胞增殖中的作用[J].解剖学研究,2018,40(3):174-177.
[12]
FU H B, WANG C M, YANG D J, et al.Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling [J].J Cell Physiol, 2018, 233(6): 4634-4642.
[13]
王晶宇,王志平,赵俊丽,等.姜黄素作用PTEN/PI3K/AKT通路诱导膀胱癌EJ细胞凋亡[J].中药药理与临床,2011,27(1):26-28.
[14]
SHA J, LI J S, WANG W, et al.Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling [J].Biomed Pharmacother, 2016, 84: 177-184.
[15]
MOU S F, ZHOU Z X, HE Y K, et al.Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a [J].Oncol Lett, 2017, 14(4): 4937-4942.
[16]
AL-KAHTANI M, ABDEL-DAIM M M, SAYED A A, et al.Curcumin phytosome modulates aluminum-induced hepatotoxicity via regulation of antioxidant, Bcl-2, and caspase-3 in rats [J].Environ Sci Pollut Res Int, 2020, 27(17): 21977-21985.
[17]
HARAKEH S, SABER S H, AL-RADDADI R, et al.Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells [J].Artif Cells Nanomed Biotechnol, 2023, 51(1): 361-370.
[18]
AGUDELO D, BOURASSA P, BÉRUBÉ G, et al.Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity [J].J Photochem Photobiol B, 2016, 158: 274-279.
[19]
ZHENG T S, WANG J B, SONG X, et al.Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways [J].J Cancer Res Clin Oncol, 2010, 136(10): 1597.
[20]
MANNA S K, GANGADHARAN C, EDUPALLI D, et al.Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells [J].J Biol Chem, 2013, 288(9): 8562.
[21]
SUMIRTANURDIN R, SUNGKAR S, HISPRASTIN Y, et al.Molecular docking simulation studies of curcumin and its derivatives as cyclin-dependent kinase 2 inhibitors [J].Turk J Pharm Sci, 2020, 17(4): 417-423.
[22]
GAO X L, LEONE G W, WANG H Z.Cyclin D-CDK4/6 functions in cancer [J].Adv Cancer Res, 2020, 148: 147-169.
[23]
SHIMIZU A, NISHIDA J, UEOKA Y, et al.CyclinG contributes to G2/M arrest of cells in response to DNA damage [J].Biochem Biophys Res Commun, 1998, 242(3): 529-533.
[24]
YANG T S, XIAO Y, LIU S, et al.Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer [J].Phytomedicine, 2023, 114: 154780.
[25]
CHUEAHONGTHONG F, TIMA S, CHIAMPANICHAYAKUL S, et al.Co-treatments of edible curcumin from turmeric rhizomes and chemotherapeutic drugs on cytotoxicity and FLT3 protein expression in leukemic stem cells [J].Molecules, 2021, 26(19): 5785.
[26]
ZHU D J, LI Y, ZHANG Z J, et al.Recent advances of nanotechnology-based tumor vessel-targeting strategies [J].J Nanobiotechnology, 2021, 19(1): 435.
[27]
陈彩萍,徐琦,赵海菲.姜黄素对肝癌细胞miR-29及VEGF表达的干预作用[J].浙江中西医结合杂志,2020,30(10):785-790.
[28]
杨传玉,曾荣耀,刘荣亮,等.姜黄素对化学诱导大鼠肝癌缺氧模型血管生成的影响[J].中国肿瘤生物治疗杂志,2018,25(2):137-141.
[29]
WANG C Y, ZHANG R S, HE J, et al.Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity [J].Nat Commun, 2023, 14(1): 3877.
[30]
SYUKRI A, BUDU, HATTA M, et al.Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage [J].Ann Med Surg (Lond), 2022, 76: 103501.
[31]
FINCK A, GILL S I, JUNE C H.Cancer immunotherapy comes of age and looks for maturity [J].Nat Commun, 2020, 11(1): 3325.
[32]
KROEMER G, GALASSI C, ZITVOGEL L, et al.Immunogenic cell stress and death [J].Nat Immunol, 2022, 23(4): 487-500.
[33]
FAROOQI A A, LI K T, FAYYAZ S, et al.Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress [J].Tumour Biol, 2015, 36(8): 5743-5752.
[34]
MAU B L, POWIS G.Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin.Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity [J].Biochem Pharmacol, 1992, 43(7): 1621-1627.
[35]
QI J, JIN F Y, YOU Y C, et al.Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles [J].Nat Commun, 2021, 12(1): 4755.
[36]
WANG J, WANG Y, LIU Q, et al.Rational design of multifunctional dendritic mesoporous silica nanoparticles to load curcumin and enhance efficacy for breast cancer therapy[J].ACS Appl Mater Interfaces, 2016, 8(40): 26511-26523.
[37]
DAI Z, TANG J, GU Z Y, et al.Eliciting immunogenic cell death via a unitized nanoinducer [J].Nano Lett, 2020, 20(9): 6246-6254.
[38]
LI Y Q, ZHU J, YANG Y F, et al.Long-acting nanohybrid hydrogel induces persistent immunogenic chemotherapy for suppressing postoperative tumor recurrence and metastasis [J].Mol Pharm, 2023, 20(12): 6345-6357.
[39]
CAO A C, MA P Q, YANG T, et al.Multifunctionalized micelles facilitate intracellular doxorubicin delivery for reversing multidrug resistance of breast cancer [J].Mol Pharm, 2019, 16(6): 2502-2510.
[40]
ZHANG N, GAO M, WANG Z H, et al.Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level [J].J Pharm Biomed Anal, 2021, 201: 114129.
[41]
WU M F, HUANG Y H, CHIU L Y, et al.Curcumin induces apoptosis of chemoresistant lung cancer cells via ROS-regulated p38 MAPK phosphorylation [J].Int J Mol Sci, 2022, 23(15): 8248.
[42]
AN L L, WURI J, ZHENG Z T, et al.Microbiota modulate doxorubicin induced cardiotoxicity [J].Eur J Pharm Sci, 2021, 166: 105977.
[43]
朱俊峰,伊晓娇,钟里科,等.中药抗阿霉素心脏毒性的中医理论及其药理作用研究进展[J].中华中医药杂志,2022,37(8):4592-4598.
[44]
NAMDARI M, EATEMADI A.Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite(nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines [J].Artif Cells Nanomed Biotechnol, 2017, 45(4): 731-739.
[45]
CHUANG S E, YEH P Y, LU Y S, et al.Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB(NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells [J].Biochem Pharmacol, 2002, 63(9): 1709-1716.
[46]
SOMPAR N, KUKONGVIRIYAPAN V, KUKONGVIRIYAPAN U, et al.Protective effects of tetrahydrocurcumin and curcumin against doxorubicin and cadmium-induced cytotoxicity in chang liver cells [J].Trop J Pharm Res, 2015, 14(5): 769-776.
[47]
YU W, QIN X, ZHANG Y C, et al.Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner [J].Cardiovasc Diagn Ther, 2020, 10(4): 752-769.
[48]
SHARIFIAGHDAM Z, DALOUCHI F, SHARIFIAGHDAM M, et al.Curcumin-coated gold nanoparticles attenuate doxorubicin-induced cardiotoxicity via regulating apoptosis in a mouse model [J].Clin Exp Pharmacol Physiol, 2022, 49(1): 70-83.
[49]
KATAMURA M, IWAI-KANAI E, NAKAOKA M, et al.Curcumin attenuates doxorubicin-induced cardiotoxicity by inducing autophagy via the regulation of JNK phosphorylation[J].J Clin Exp Cardiol, 2014, (5): 337.
[50]
JUNKUN L, ERFU C, TONY H, et al.Curcumin downregulates phosphate carrier and protects against doxorubicin induced cardiomyocyte apoptosis [J].Biomed Res Int, 2016, 2016: 1980763.
[51]
LARGE D E, ABDELMESSIH R G, FINK E A, et al.Liposome composition in drug delivery design, synthesis, characterization, and clinical application [J].Adv Drug Deliv Rev, 2021, 176: 113851.
[52]
FAN Y C, MARIOLI M, ZHANG K.Analytical characterization of liposomes and other lipid nanoparticles for drug delivery [J].J Pharm Biomed Anal, 2021, 192(59): 113642.
[53]
MURUGESAN K, SRINIVASAN P, MAHADEVA R, et al.Tuftsin-bearing liposomes co-encapsulated with doxorubicin and curcumin efficiently inhibit EAC tumor growth in mice [J].Int J Nanomedicine, 2020, 15: 10547-10559.
[54]
陈仕红.姜黄素和阿霉素双载药靶向脂质体的制备及抗肿瘤活性研究[D].武汉:湖北中医药大学硕士学位论文,2019.
[55]
HWANG D, RAMSEY J D, KABANOV A V.Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval [J].Adv Drug Deliv Rev, 2020, 156: 80-118.
[56]
GU Y, LI J, LI Y, et al.Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer [J].Int J Nanomedicine, 2016, 11: 5757-5770.
[57]
SABZI A, RAHMANI A, EDALATI M, et al.Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized poly(ε-caprolactone) based micelle in MDA-MB-231 cell [J].Colloids Surf B Biointerfaces, 2020, 194: 111225.
[58]
ÖZKAN SA, DEDEOĞLU A, KARADAŞ BAKIRHAN N, et al.Nanocarriers used most in drug delivery and drug release: nanohydrogel, chitosan, graphene, and solid lipid [J].Turk J Pharm Sci, 2019, 16(4): 481-492.
[59]
ABEDI F, DAVARAN S, HEKMATI M, et al.An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells [J].J Nanobiotechnology, 2021, 19(1): 18.
[60]
RONG L D, LIU Y, FAN Y, et al.Injectable nano-composite hydrogels based on hyaluronic acid-chitosan derivatives for simultaneous photothermal-chemo therapy of cancer with anti-inflammatory capacity [J].Carbohydr Polym, 2023, 310: 120721.
[61]
WANG Z J, TONG Q, LI T, et al.Nano drugs delivery system: a novel promise for the treatment of atrial fibrillation[J].Front Cardiovasc Med, 2022, 9: 906350.
[62]
GUO F Y, YU N, JIAO Y L, et al.Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer [J].Drug Deliv, 2021, 28(1): 1709-1721.
[63]
LIU J, LI L, ZHANG B, et al.MnO2-shelled doxorubicin/curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy [J].J Colloid Interface Sci, 2022, 617: 315-325.
[64]
YE J H, AUGUSTIN M A.Nano- and micro-particles for delivery of catechins: physical and biological performance [J].Crit Rev Food Sci Nutr, 2019, 59(10): 1563-1579.
[65]
LIN J T, YE Q B, YANG Q J, et al.Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin [J].Colloids Surf B Biointerfaces, 2019, 180: 93-101.
2024年第55卷第12期
34
10
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.12.003
  • 接收时间:2023-12-28
  • 首发时间:2026-11-18
  • 出版时间:2024-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-12-28
基金
作者信息
    江西科技师范大学药学院,江西省药物分子设计与评价重点实验室,江西 南昌 330013

通讯作者:

陈振华(1982—),男,教授,从事药物新剂型及质量评价的研究。E-mail:
周良良(1986—),男,讲师,从事中药制剂的研究与开发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.12.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏